EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis

LABRHA is supporting Eurovisco by organizing its annual board since 2014.We are proud to be Eurovisco’s partner. Abstract Objective: Viscosupplementation (VS) by intra-articular injections of hyaluronic acid (HA) is a commonly used treatment of knee osteoarthritis. However, there are no clear recommendations for its use in clinical situations not usually Read more…

EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip Osteoarthritis

LABRHA is supporting Eurovisco by organizing its annual board since 2014.We are proud to be Eurovisco’s partner. Abstract The European Viscosupplementation Consensus Group (EUROVISCO) has published expert recommendations on the use of hyaluronic acid (HA) injections, also known as viscosupplementation, in the management of hip osteoarthritis. Based on a comprehensive Read more…